Circio is preparing to advance its circular RNA gene therapy [...]

HAYA Therapeutics has received FDA Fast Track designation for HTX-001, [...]

Skyhawk Therapeutics has expanded its global pivotal Phase 2/3 clinical [...]

Resalis Therapeutics has dosed the first participant in a Phase [...]

Thalia Therapeutics has agreed a Sanmirna acquisition and £2.75m fundraise [...]

The Alliance for mRNA Medicines (AMM) and the Society for [...]

spliesense-cystic-fibrosis-foundation-spl84-phase2b SpliSense has secured up to $13 million in funding [...]

The Society for RNA Therapeutics (SRT) has expanded its leadership [...]

Skyhawk Therapeutics has reported encouraging 12-month results from its ongoing [...]

Bonito Biosciences has entered a collaboration with DaltonTx to develop [...]